A twelve-week journey through the SYL System. Every test result, biomarker shift, intervention, and outcome — laid out in full. What it actually looks like when a high-performing ADHD founder rebuilds their architecture.
Diagnosed ADHD at 36. By Year 7 of the company, Marcus has built a 140-person team, raised a Series B, and shipped two product lines. He has also been deferring three significant decisions for weeks. His HRV has been trending sideways for fourteen months. His afternoon meetings increasingly happen through fog.
Sunday, 3:18 PM. Marcus is on the sofa. The house is quiet in the particular way it is quiet only on a Sunday afternoon. He should feel restored. He feels nothing. Tomorrow there is a board call at nine, a hiring decision he has been deferring for three weeks. He has been deferring everything for three weeks.
He takes the four short tests. The results are honest, and not surprising — but seeing them in numbers is different from feeling them. The Threshold Clock sits at the edge of "stabilise first." We extend his Pre-Phase from two weeks to four. He receives the kits.
Pre-Phase extended from 2 → 4 weeks. Threshold score below 60 triggers stabilisation-first protocol.
Swiss-grade blood panel kit, 24h HRV monitor, 14-day CGM, saliva cortisol kit — all delivered to Marcus's home.
Marcus runs the full diagnostic stack while light micro-change starts across all four life dimensions at ~20% intensity. By the end of Month 1, he has more data on his biology than he has had in his entire adult life — and several patterns he had not been ready to see.
Marcus's panel returned a clean signal. Inflammation elevated (hs-CRP 4.2 mg/L — high-cardiovascular-risk band). Methylation impaired (homocysteine 14.1 µmol/L). Omega-3 index at 3.8% — well below the 8% target. Vitamin D at 18 ng/ml — deficient. Magnesium RBC low. Mitochondrial markers (organic acids) showed reduced ATP production, suggesting the system was running on fumes. HRV phenotype: sympathetic-dominant, low vagal tone, shallow recovery. None of this had shown up in his consumer wearable.
5-min vagal breathing pre-coffee. 15-min walk in daylight pre-9am. Both stack onto existing morning architecture.
Three prompts, three minutes, three times/week. Begins mapping the dominant Achiever and atrophied Visionary.
One non-negotiable, screen-free, two hours. The relational fabric the company runs on starts being protected.
Voice notes → ChatGPT structuring → action items. Tested for two weeks. Marcus reduces email-avoidance time by ~40%.
Phase ii. begins with the diagnostic findings on the table. The plan is not generic — every intervention is calibrated to Marcus's specific biology, his PSI profile, and his role. The architecture of his next twelve months is being designed alongside him.
Marcus's plan is not a vitamin grab-bag. It is built from the panel: methylated B-complex (homocysteine high), omega-3 EPA/DHA 3g/day (index at 3.8%), vitamin D 5000 IU + K2, magnesium glycinate 400mg pre-sleep, NAD+ precursor (mitochondrial markers), and a CGM-driven nutrition pattern that flattens the post-lunch glucose crash. Reviewed by Vitareba's clinical team.
6 substances, dosed to panel. Reviewed at week 8 and week 12.
Glucose-stabilising plate architecture. Flattens 14:00 crash within 10 days.
Marcus integrates VITAE's breath, regulation & recovery work — three short daily protocols, one weekly long session. The mechanism is direct: vagal tone trains over 4–6 weeks, HRV climbs, sleep architecture deepens. By week 8, his CGM nights show genuine recovery for the first time in two years.
Three times/day, 5 min. Pre-meeting, pre-lunch, pre-sleep.
45 min. Resets vagal baseline at the end of each week.
PSI Diagnostic confirmed it on day zero: Marcus's Achiever (Red Office) is over-developed, his Visionary (Yellow Library) atrophied. Phase ii. work is to deliberately train the Visionary — not as a self-help abstraction, but as a specific room with specific practices: weekly long-form writing (no AI), 30-min walks without phones, a Saturday-morning practice of integration. By week 9, Marcus's first meaningful product-strategy decision in a quarter comes from the Yellow room. Not the Red.
Marcus and the SYL team build his personal GPT stack — five custom GPTs, each one trained on a specific role. Strategy GPT for board-deck drafting and product narrative. Health GPT linked to his biomarker dashboard. Inner Team GPT for daily journaling, trained in PSI language. Recovery Coach GPT tied to his HRV and sleep data. Decision GPT structured around his three deferred decisions. By week 10, two of those three decisions are made.
No transformation arc is linear. Marcus had two genuinely difficult weeks — one around week 6, one around week 9. But by week 12, both the subjective and objective markers had moved. And several months on, the changes have held.
"For seven years I built the company on adrenaline and a kind of wilful tunnel vision. By Year 7 the company didn't need that any more — but my body didn't know how to do anything else. The SYL System didn't make me a different person. It gave me access to a part of myself that had been quiet for a decade. The Visionary is back. The Achiever is still there — but now it serves the Visionary instead of the other way around."
If something in Marcus's journey rings true — the deferred decisions, the sideways HRV, the Achiever doing the work the Visionary should be doing — there is a fifteen-minute call that takes you to the next step. No pressure. No sales pitch. Just a conversation about whether the architecture is the right fit.